Psoriasis
https://en.wikipedia.org/wiki/Psoriasis
☆ AI Dermatology — Free ServiceKwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo. relevance score : -100.0%
References
Psoriasis 28846344 NIH
Phototherapy 33085287 NIH
Tumor Necrosis Factor Inhibitors 29494032 NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).
Unyango olwahlukeneyo lunokunceda ukulawula iimpawu. Olu nyango lubandakanya i‑steroid creams, i‑vitamin D3 cream, ukukhanya kwe‑ultraviolet, kunye neziyobisi ze‑immunosuppressive, ezifana ne‑methotrexate. Malunga ne‑75 % yokubandakanyeka kwesikhumba kuphuculwa ngeekhrimu ezodwa. Iintlobo ezahlukeneyo ze‑biological immunologic agents ziphuhliswa kunyango lwe‑psoriasis.
I‑psoriasis yingxaki eqhelekileyo kwaye ichaphazela i‑2‑4 % yabemi. Amadoda nabasetyhini bachaphazeleka ngokulinganayo. Esi sifo singavela nakweyiphi na iminyaka, kodwa ngokuqhelekileyo siqala ebudaleni. I‑psoriatic arthritis ichaphazela ukuya kuthi ga kwi‑30 % yabantu abane‑psoriasis.
○ Unyango ― OTC Amachiza
Ukukhanya kwelanga kunokunceda i‑psoriasis kuba kubangela utshintsho lwe‑immunological kwizigulane ezine‑psoriasis. I‑ointment ye‑hydrocortisone encinci inokunceda ukunyanga izilonda ezincinci ze‑psoriasis.
#OTC steroid ointment
○ Unyango
I‑psoriasis sisifo esinganyangekiyo, kwaye uninzi lwee‑therapies zonyango ziyafundwa. Iibhayoloji ezisebenzayo kodwa zibiza kakhulu.
#High potency steroid ointment
#Calcipotriol cream
#Phototherapy
#Biologics (e.g. infliximab, adalimumab, secukinumab, ustekinumab)